Health Equity amd SDoH Implementation Congress 2024 | Kisaco Research | 7 May 2024 | TBA, Atlanta, GA

A solution-focused and educational experience, uniting the health equity and clinical research ecosystems to collaborate and optimise data-driven initiatives. With both educational and informative angles, discover what is being done for health equity to produce data-driven results in patient engagement, recruitment, retention, and experience. Bring your brainstorming cap and enter 2 days of collaborative content designed to spark ideas, form connections, and improve your approaches to diversity, equity, and inclusion in clinical trials. Designed with collaboration in mind and includes extended networking, roundtable activities, and an open town-hall Q&A.

2024 Speakers

Kim Fookes
Global Head, Diversity & Inclusion in Clinical Trial, Novartis

Sandra Amaro
Head of Clinical Trial Diversit, Pfizer

Tabia Henry Akintobi
Associate Dean for Community Engagement, Principal Investigator, Morehouse School of Medicine

Martin Mendoza
Director of Health Equity, National Institute of Health

Rajbir Singh
Principal Investigator, Meharry Medical College

Edie Stringfellow
Vice President of Ecosystem Development, Center for Global Health Innovation

Michel Reid
Global Head of Demographics & Diversity, GSK

Kemi Willaims
Senior Director, Patient Science, AstraZeneca

Mary Nwokedi
Director, Clinical Trial Diversity: Science and Regulatory Advocacy, PhRMA

LaTrisha Horne
Associate Director of Precision Medicine Implementation, Morehouse School of Medicine

Benjamin Young
Senior Global Medical Director, ViiV Healthcare

Keri Norris
Vice President, Health Equity & DEI, National Blood Disorders Foundation

Wenora Johnson
Administrative Support Chain Reaction Innovations, Argonne National Laboratory

Grayson Schultz
Patient Expert, Consultant and Coach, Grayson Schultz Consulting

Alana Miller
Associate Director, Diversity in Clinical Trials, Merck

Donald Alcendor
Director of Research, Meharry Medical College

Kimberly Doggett
Head of Clinical Trial Diversity, UCB

Savine DaCosta
Clinical Trial Diversity Lead, Biogen

Brittany Gerald
Senior Manager Sr. Manager, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE), Moderna

Gabrielle Jones
Vice President, Community Engagement & Advocacy, HEAL COLLABORATIVE

Denise Bronner
Director of Diversity, Equity and Inclusion in Clinical Trials, Janssen

Renarda Jones
Chief Executive Officer, Diverse Research Now

Keith Dawson
Principal Global Health Equity & Population Science, Genentech

Amy Ben-Arieh
Director of Research Compliance, Fenway Health

Lashell Robinson
Director, Diversity & Inclusion in Clinical Trials, Takeda Pharmaceuticals

Rachel Barron
Senior Manager, Health Equity, Global Genes

Keri Norris
Vice President, Health Equity & DEI, National Blood Disorders Foundation

Myra Parker
Associate Professor, University of Washington

Yamile Molina
Director of Community Engagement, University of Illinois Cancer Center

Terri Wiggins
Senior Vice President, Health Equity, American Diabetes Association

Dan Hartman
Director, Integrated Development, Bill & Melinda Gates

Socrates Trujillo
Division Director, FDA